Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-02-05 Purchase | 2025-02-07 4:21 pm | Tectonic Therapeutic Inc. | TECX | SPRINGER TIMOTHY A Director 10% Owner | 789,294 | $50.68 | $39,999,977 | 5,382,415 (Indirect Direct) | View |
2025-02-05 Purchase | 2025-02-07 4:19 pm | Tectonic Therapeutic Inc. | TECX | Lochner Daniel Chief Financial Officer | 4,617 | $54.14 | $249,964 | 4,617 (Direct) | View |
2024-10-22 Purchase | 2024-10-24 5:04 pm | Tectonic Therapeutic Inc. | TECX | SPRINGER TIMOTHY A Director 10% Owner | 300,000 | $33.59 | $10,077,000 | 4,593,121 (Indirect Direct) | View |
2024-09-26 Purchase | 2024-09-26 6:15 pm | Tectonic Therapeutic Inc. | TECX | SPRINGER TIMOTHY A Director 10% Owner | 50,000 | $28.82 | $1,440,829 | 6,464,684 (Indirect Direct) | View |
2024-05-13 Purchase | 2024-05-15 11:21 am | AVROBIO Inc. | AVRO | Leonard Braden Michael 10% Owner | 766,635 | $1.2672 | $971,493 | 5,168,262 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-02-04 Option Award | 2025-02-06 4:05 pm | N/A 2035-02-03 | Tectonic Therapeutic Inc. | TECX | Schwabish Marc Chief Business Officer | 39,519 | $0 | 44,219 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:05 pm | N/A 2035-02-03 | Tectonic Therapeutic Inc. | TECX | McNamara Peter Chief Scientific Officer | 42,671 | $0 | 56,859 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:05 pm | N/A 2035-02-03 | Tectonic Therapeutic Inc. | TECX | Lochner Daniel Chief Financial Officer | 50,936 | $0 | 50,936 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:05 pm | N/A 2035-02-03 | Tectonic Therapeutic Inc. | TECX | Ruddy Marcella K. Chief Medical Officer | 50,378 | $0 | 82,443 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:05 pm | N/A 2035-02-03 | Tectonic Therapeutic Inc. | TECX | REICIN ALISE Chief Executive Officer | 138,000 | $0 | 440,827 (Direct) | View |
2025-01-28 Exercise | 2025-01-29 4:05 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | Schwabish Marc Chief Business Officer | 2,700 | $0 | 91,214 (Direct) | View |
2025-01-28 Exercise | 2025-01-29 4:05 pm | N/A N/A | Tectonic Therapeutic Inc. | TECX | Schwabish Marc Chief Business Officer | 2,700 | $2.38 | 91,214 (Direct) | View |
2024-12-09 Exercise | 2024-12-11 4:21 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | Schwabish Marc Chief Business Officer | 2,000 | $0 | 91,214 (Direct) | View |
2024-12-09 Exercise | 2024-12-11 4:21 pm | N/A N/A | Tectonic Therapeutic Inc. | TECX | Schwabish Marc Chief Business Officer | 2,000 | $2.38 | 91,214 (Direct) | View |
2024-12-04 Option Award | 2024-12-06 5:19 pm | N/A 2034-12-03 | Tectonic Therapeutic Inc. | TECX | REICIN ALISE Chief Executive Officer | 17,717 | $0 | 308,827 (Direct) | View |
2024-12-03 Exercise | 2024-12-05 4:32 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | McNamara Peter Chief Scientific Officer | 3,500 | $0 | 48,647 (Direct) | View |
2024-12-03 Exercise | 2024-12-05 4:32 pm | N/A N/A | Tectonic Therapeutic Inc. | TECX | McNamara Peter Chief Scientific Officer | 3,500 | $2.38 | 48,647 (Direct) | View |
2024-09-24 Other | 2024-09-26 6:15 pm | N/A N/A | Tectonic Therapeutic Inc. | TECX | SPRINGER TIMOTHY A Director 10% Owner | 2,481,786 | $0 | 6,464,684 (Indirect) | View |
2024-06-20 Other | 2024-06-25 1:42 pm | N/A N/A | Tectonic Therapeutic Inc. | TECX | Leonard Braden Michael Former 10% owner of AVROBIO | 433,688 | $0 | 867,376 (Indirect) | View |
2024-06-20 Option Award | 2024-06-24 4:37 pm | N/A 2034-06-19 | Tectonic Therapeutic Inc. | TECX | Donenberg Phillip B. Director | 11,760 | $0 | 11,760 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:35 pm | N/A 2034-06-19 | Tectonic Therapeutic Inc. | TECX | Vitorovic Stefan Director | 1,040,434 | $0 | 39,534 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:32 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | Tipirneni Praveen P. Director | 26,963 | $0 | 26,963 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:30 pm | N/A 2034-06-19 | Tectonic Therapeutic Inc. | TECX | SPRINGER TIMOTHY A Director 10% Owner | 4,254,881 | $0 | 4,254,881 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:27 pm | N/A 2034-06-19 | Tectonic Therapeutic Inc. | TECX | MCGUIRE TERRANCE Director | 1,169,736 | $0 | 76,412 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:25 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | Schwabish Marc Chief Business Officer | 160,830 | $0 | 160,830 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:22 pm | N/A 2031-09-16 | Tectonic Therapeutic Inc. | TECX | Ruddy Marcella K. Chief Medical Officer | 176,415 | $0 | 176,415 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:20 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | McNamara Peter Chief Scientific Officer | 176,416 | $0 | 176,416 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:18 pm | N/A 2034-06-19 | Tectonic Therapeutic Inc. | TECX | Lochner Daniel Chief Financial Officer | 118,000 | $0 | 118,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:16 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | Cortis Christian Chief Operating Officer | 201,133 | $0 | 201,133 (Direct) | View |
2024-06-20 Option Award | 2024-06-24 4:12 pm | N/A 2031-06-27 | Tectonic Therapeutic Inc. | TECX | REICIN ALISE Chief Executive Officer | 638,013 | $0 | 638,013 (Direct) | View |
Ownership(A) | 2024-05-15 10:51 am | N/A N/A | AVROBIO Inc. | AVRO | Leonard Braden Michael 10% Owner | 0 | $0 | 4,871,380 (Indirect) | View |
Ownership | 2024-05-15 10:31 am | N/A N/A | AVROBIO Inc. | AVRO | Leonard Braden Michael 10% Owner | 0 | $0 | 4,471,380 (Indirect) | View |
2024-02-01 Exercise | 2024-02-05 8:01 pm | N/A 2027-02-01 | AVROBIO Inc. | AVRO | Golipour Azadeh Chief Technology Officer | 37,334 | $0 | 167,871 (Direct) | View |
2024-02-05 Tax Withholding | 2024-02-05 8:01 pm | N/A N/A | AVROBIO Inc. | AVRO | Golipour Azadeh Chief Technology Officer | 12,232 | $1.2016 | 167,871 (Direct) | View |
2024-02-05 Tax Withholding | 2024-02-05 7:59 pm | N/A N/A | AVROBIO Inc. | AVRO | Ridha Essra Chief Medical Officer | 16,953 | $1.2006 | 114,380 (Direct) | View |
2024-02-01 Exercise | 2024-02-05 7:59 pm | N/A 2027-02-01 | AVROBIO Inc. | AVRO | Ridha Essra Chief Medical Officer | 32,834 | $0 | 114,380 (Direct) | View |